Aug 09, 2023 / 02:00PM GMT
Jon Young - Canaccord Genuity - Analyst
Good morning, everyone. Thank you for joining us at Canaccord's 43rd Annual Global Growth Conference. I'm Jon Young, a member of the medtech research team here.
It's my pleasure to host STAAR Surgical. With us today is Tom Frinzi, President and CEO; and Patrick Williams, CFO. So thank you both for joining us today. The format is a brief overview presentation of the company, followed by a fireside chat Q&A.
And with that, I'd like to invite Tom to the podium. Thank you.
Tom Frinzi - STAAR Surgical Company - Chair of the Board, President, & CEO
Thanks, Jon. Good morning, everyone. It's certainly a pleasure to be here in Boston. Bill, Jon, thank you for the invitation. How do I click through here? Oh, there it is. Okay, there we go.
Here's our Safe Harbor relative to forward-looking statements. And let me start by introducing STAAR to you by introducing myself. Again, as Jon said, my name is Tom Frinzi. I've been the CEO of the company since January of this year. I've been on the Board
STAAR Surgical Co at Canaccord Genuity Growth Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot